Immunopathological studies of Leishmania amazonensis infection in resistant and in susceptible mice
- PMID: 20462353
- DOI: 10.1086/652870
Immunopathological studies of Leishmania amazonensis infection in resistant and in susceptible mice
Abstract
Leishmania amazonensis infection was studied in mice to evaluate the evolution of leishmaniasis. The association of different methods, such as lesion kinetics, limiting dilution analysis, and immunohistochemistry, established different levels of susceptibility and resistance. Mice were arranged in 3 groups: susceptible (C57BL/10 and CBA), relatively resistant (DBA/2), and resistant (C3H.He). The histopathological analysis of primary lesions and draining lymph nodes showed a predominance of eosinophils and mast cells in the initial phase of infection in all mice. However, the most susceptible mice presented a greater number of amastigotes and higher tissue damage. The immunoglobulin analysis showed that susceptible mice produced high levels of antibodies, whereas resistant and relatively resistant mice exhibited low production of antibodies. Resistant mice showed parasite persistency in the skin and lymph nodes, suggesting that the infection in these mice can be sustained through the infection of cells such as dendritic cells, fibroblasts, and other cells present in these organs.
Similar articles
-
The histopathological and immunological pattern of CBA mice infected with Leishmania amazonensis after treatment with pyrazole carbohydrazide derivatives.Exp Parasitol. 2013 Feb;133(2):201-10. doi: 10.1016/j.exppara.2012.11.022. Epub 2012 Dec 5. Exp Parasitol. 2013. PMID: 23219949
-
Mast cells are activated by Leishmania mexicana LPG and regulate the disease outcome depending on the genetic background of the host.Parasite Immunol. 2008 Aug;30(8):425-34. doi: 10.1111/j.1365-3024.2008.01042.x. Parasite Immunol. 2008. PMID: 18507782
-
Histopathological studies of visceralized Leishmania (Leishmania) amazonensis in mice experimentally infected.Vet Parasitol. 2004 May 26;121(3-4):179-87. doi: 10.1016/j.vetpar.2004.03.002. Vet Parasitol. 2004. PMID: 15135858
-
Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.Behring Inst Mitt. 1997 Feb;(98):153-9. Behring Inst Mitt. 1997. PMID: 9382736 Review.
-
Tissue damage and immunity in cutaneous leishmaniasis.Parasite Immunol. 2012 Dec;34(12):551-61. doi: 10.1111/pim.12007. Parasite Immunol. 2012. PMID: 23009296 Review.
Cited by
-
Eosinophils, but Not Type 2 Innate Lymphoid Cells, Are the Predominant Source of Interleukin 4 during the Innate Phase of Leishmania major Infection.Pathogens. 2022 Jul 25;11(8):828. doi: 10.3390/pathogens11080828. Pathogens. 2022. PMID: 35894051 Free PMC article.
-
Characterization of cross-protection by genetically modified live-attenuated Leishmania donovani parasites against Leishmania mexicana.J Immunol. 2014 Oct 1;193(7):3513-27. doi: 10.4049/jimmunol.1303145. Epub 2014 Aug 25. J Immunol. 2014. PMID: 25156362 Free PMC article.
-
The Roles of Mast Cells in Parasitic Protozoan Infections.Front Immunol. 2017 Apr 6;8:363. doi: 10.3389/fimmu.2017.00363. eCollection 2017. Front Immunol. 2017. PMID: 28428784 Free PMC article. Review.
-
Efficacy of Paromomycin-Chloroquine Combination Therapy in Experimental Cutaneous Leishmaniasis.Antimicrob Agents Chemother. 2017 Jul 25;61(8):e00358-17. doi: 10.1128/AAC.00358-17. Print 2017 Aug. Antimicrob Agents Chemother. 2017. PMID: 28607026 Free PMC article.
-
Amentoflavone as an Ally in the Treatment of Cutaneous Leishmaniasis: Analysis of Its Antioxidant/Prooxidant Mechanisms.Front Cell Infect Microbiol. 2021 Feb 25;11:615814. doi: 10.3389/fcimb.2021.615814. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 33718267 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources